Dossier
geographic atrophy
Coverage of geographic atrophy in the Nexus archive.
- Stem Cell Therapy for GA Shows Early Evidence of Vision Gains, Retina Preservation
A stem cell-derived therapy for advanced geographic atrophy (GA) showed preliminary evidence of vision improvement and retina preservation, according to a small study reported in Montreal. The study indicated potential benefits in preserving retinal health and enhancing visual acuity in patients with advanced GA.
- Vision Benefits in GA With Complement Inhibitor, Regardless of AMD, Anti-VEGF
Pegcetacoplan (Syfovre), a complement inhibitor, showed similar efficacy in treating geographic atrophy (GA) whether administered to patients with concurrent neovascular age-related macular degeneration (nAMD) or to those with GA alone. The findings are based on data from a retina clinical trial.